Medicon Hellas S.A. (ATH:MEDIC)

Market Cap	11.54M +23.1%
Revenue (ttm)	18.54M +6.6%
Net Income	1.90M +131.1%
EPS	0.43 +131.1%
Shares Out	4.42M
PE Ratio	6.21
Forward PE	n/a
Dividend	0.13 (5.12%)
Ex-Dividend Date	Jul 4, 2025

Volume	4,427
Average Volume	3,183
Open	2.540
Previous Close	2.540
Day's Range	2.540 - 2.630
52-Week Range	2.210 - 2.920
Beta	0.45
RSI	63.52
Earnings Date	Apr 30, 2026

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, work flow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology and immunochemistry reagents. In addition, it offers analyzers, reagents, contro...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 151
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: MEDIC

Financial Performance

In 2024, Medicon Hellas's revenue was 18.12 million, an increase of 0.03% compared to the previous year's 18.12 million. Earnings were 1.37 million, an increase of 3.38%.